HM Payson & Co’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $3.38K | Hold |
1,000
| – | – | ﹤0.01% | 932 |
|
2024
Q4 | $5.67K | Hold |
1,000
| – | – | ﹤0.01% | 890 |
|
2024
Q3 | $5.85K | Hold |
1,000
| – | – | ﹤0.01% | 891 |
|
2024
Q2 | $7.91K | Hold |
1,000
| – | – | ﹤0.01% | 856 |
|
2024
Q1 | $9.31K | Buy |
1,000
+500
| +100% | +$4.66K | ﹤0.01% | 825 |
|
2023
Q4 | $4.22K | Hold |
500
| – | – | ﹤0.01% | 873 |
|
2023
Q3 | $3.88K | Hold |
500
| – | – | ﹤0.01% | 892 |
|
2023
Q2 | $5.73K | Hold |
500
| – | – | ﹤0.01% | 844 |
|
2023
Q1 | $3.86K | Hold |
500
| – | – | ﹤0.01% | 874 |
|
2022
Q4 | $3.05K | Hold |
500
| – | – | ﹤0.01% | 837 |
|
2022
Q3 | $3K | Hold |
500
| – | – | ﹤0.01% | 896 |
|
2022
Q2 | $3K | Hold |
500
| – | – | ﹤0.01% | 936 |
|
2022
Q1 | $4K | Hold |
500
| – | – | ﹤0.01% | 936 |
|
2021
Q4 | $1K | Sell |
500
-2,000
| -80% | -$4K | ﹤0.01% | 1062 |
|
2021
Q3 | $7K | Hold |
2,500
| – | – | ﹤0.01% | 870 |
|
2021
Q2 | $10K | Hold |
2,500
| – | – | ﹤0.01% | 822 |
|
2021
Q1 | $12K | Buy |
2,500
+200
| +9% | +$960 | ﹤0.01% | 855 |
|
2020
Q4 | $16K | Hold |
2,300
| – | – | ﹤0.01% | 814 |
|
2020
Q3 | $25K | Hold |
2,300
| – | – | ﹤0.01% | 701 |
|
2020
Q2 | $29K | Hold |
2,300
| – | – | ﹤0.01% | 610 |
|
2020
Q1 | $21K | Hold |
2,300
| – | – | ﹤0.01% | 637 |
|
2019
Q4 | $32K | Hold |
2,300
| – | – | ﹤0.01% | 653 |
|
2019
Q3 | $40K | Hold |
2,300
| – | – | ﹤0.01% | 630 |
|
2019
Q2 | $63K | Buy |
+2,300
| New | +$63K | ﹤0.01% | 562 |
|